SCHEMBL13901171

SCHEMBL13901171

Nc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1Br

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 5/20 0.66
NUAK1 O60285 3/20 0.66
CSF1R P07333 2/20 0.66
TYK2 P29597 2/20 0.66
NTRK1 P04629 2/20 0.66
STK16 O75716 1/20 0.66
CSNK2A2 P19784 1/20 0.66
AAK1 Q2M2I8 1/20 0.66
ULK3 Q6PHR2 1/20 0.66
BMP2K Q9NSY1 1/20 0.66
PLK4 O00444 1/20 0.62
MARK3 P27448 3/20 0.62
MARK4 Q96L34 3/20 0.62
STK17A Q9UEE5 3/20 0.62
CDK1 P06493 1/20 0.60
KDR P35968 1/20 0.60
ULK2 Q8IYT8 3/20 0.55
IKBKE Q14164 2/20 0.55
SIK2 Q9H0K1 2/20 0.52
ACVR1 Q04771 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL270735 0.87 PLK4 (0.60) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL13897571 0.82 TBK1 (0.68) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL1571728 0.82 TBK1 (0.58) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL29370869 0.81 CDK1 (0.63) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL4875509 0.80 PLK4 (0.64) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL1571328 0.80 TBK1 (0.53) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL28153587 0.78 PLK4 (0.56) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL12423160 0.78 JAK2 (0.61) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL13897748 0.77 MARK3 (0.74) TBK1NUAK1CSF1RTYK2NTRK1
SCHEMBL13901338 0.77 CDK1 (0.53) TBK1NUAK1CSF1RTYK2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 US disclosed